IL1B and Alzheimer disease: Experimental studies have shown that diabetic patients release pro-inflammatory cytokines such as IL-1β, IL-6, and TNF-α, which may lead to neuronal death and accelerate neurodegenerative changes in Alzheimer’s disease (AD) (Puig et al., 2012).